BIIB
Biogen Inc. · Healthcare · Drug Manufacturers - General
TECHNeutralZACKSHold
R500#445 today
$219.88
-1.32% today · -3.39% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- BIIB −1.32% on the last session vs SPY +0.74%: −2.1 pts of stock-specific move.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $32.5B
- Held by institutions
- 99.5%
- Short interest
- 4.4%
- 52-week range
- 138.00–230.49
- Analyst mean target
- —
- Next earnings
- Oct 28 BMO
- Forward P/E
- 13.3
Recent events
Earnings ▲
2Q2026 results: EPS $3.60 vs $2.03 expected beat +$1.57 (+77.4%); revenue $2.7B; next session +1.8% (+3.3 vs SPY)Earnings ▲
1Q2026 results: EPS $3.57 vs $2.95 expected beat +$0.62 (+20.9%); revenue $2.5B; next session +6.0% (+6.0 vs SPY)Earnings ▲
4Q2025 results: EPS $1.99 vs $1.62 expected beat +$0.37 (+23.2%); revenue $2.3B; next session +8.5% (+6.6 vs SPY)